Insider · CIK 0001760737

Ladone Mary Kay

Reports to the SEC for 5 companies · KIRKLAND, WA

sec.gov

Transactions

Companies

Filings

CIK

0001760737

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-09	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.A Award	Director	AAward	+7,217 sh	—	—	44,724
2026-09-08	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.S Sale	Director	SSale	−3,908 sh	$25.20	−$98.5K	37,507
2026-06-05	INGNInogen IncA Award	Director	AAward	+28.1K sh	—	—	104,966
2026-06-03	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+25.1K sh	—	—	25,146
2026-06-02	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+32.3K sh	—	—	111,263
2026-06-02	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−32.3K sh	—	—	0
2026-01-02	NOVTNOVANTA INCM Exercise/Conversion	Director	MExercise/Conversion	+1,325 sh	—	—	1,897
2026-01-02	NOVTNOVANTA INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,325 sh	—	—	0
2026-01-02	NOVTNOVANTA INC · Restricted Stock UnitsA Award	Director	AAward	+1,799 sh	—	—	1,799
2025-09-04	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.A Award	Director	AAward	+10.9K sh	—	—	23,903
2025-07-11	NOVTNOVANTA INCM Exercise/Conversion	Director	MExercise/Conversion	+572 sh	—	—	572
2025-07-11	NOVTNOVANTA INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−572 sh	—	—	0
2025-06-03	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+32.3K sh	—	—	32,282
2025-06-02	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+26.5K sh	—	—	78,981
2025-06-02	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−26.5K sh	—	—	0
2025-05-14	INGNInogen IncA Award	Director	AAward	+30.6K sh	—	—	76,885
2025-01-02	NOVTNOVANTA INC · Restricted Stock UnitsA Award	Director	AAward	+1,325 sh	—	—	1,325
2024-07-11	NOVTNOVANTA INC · Restricted Stock UnitsA Award	Director	AAward	+572 sh	—	—	572
2024-06-16	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,814 sh	—	—	52,488
2024-06-16	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,814 sh	—	—	0
2024-06-11	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+26.5K sh	—	—	26,493
2024-06-07	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+30.4K sh	—	—	50,674
2024-06-07	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−30.4K sh	—	—	0
2024-06-05	INGNInogen IncA Award	Director	AAward	+21.9K sh	—	—	46,273
2023-06-16	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,813 sh	—	—	20,274
2023-06-16	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,813 sh	—	—	1,814
2023-06-07	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+30.4K sh	—	—	30,400
2023-06-06	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16.6K sh	—	—	18,461
2023-06-06	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−16.6K sh	—	—	0
2023-05-31	INGNInogen IncA Award	Director	AAward	+17.1K sh	—	—	24,402
2022-06-17	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+16.6K sh	—	—	16,648
2022-06-16	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,813 sh	—	—	1,813
2022-06-16	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,813 sh	—	—	3,627
2022-06-08	INGNInogen IncA Award	Director	AAward	+6,849 sh	—	—	7,308
2022-03-22	INGNInogen IncA Award	Director	AAward	+459 sh	—	—	459
2021-12-13	Hill-Rom Holdings, Inc.D Disposition to Issuer	SVP, Corp. Dev., Strat. & IR	DDisposition to Issuer	−2,284 sh	—	—	0
2021-12-13	Hill-Rom Holdings, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	SVP, Corp. Dev., Strat. & IR	DDisposition to Issuer	−4,102 sh	$52.89	−$217K	0
2021-12-13	Hill-Rom Holdings, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	SVP, Corp. Dev., Strat. & IR	DDisposition to Issuer	−6,054 sh	$61.86	−$375K	0
2021-12-13	Hill-Rom Holdings, Inc.Performance-Based Restricted Stock Units (11/06/2019)D Disposition to Issuer	SVP, Corp. Dev., Strat. & IR	DDisposition to Issuer	−3,947 sh	—	—	0
2021-12-13	Hill-Rom Holdings, Inc.Performance-Based Restricted Stock Units (11/11/2020)D Disposition to Issuer	SVP, Corp. Dev., Strat. & IR	DDisposition to Issuer	−4,092 sh	—	—	0
2021-12-13	Hill-Rom Holdings, Inc.Restricted Stock Units (11/06/2019)D Disposition to Issuer	SVP, Corp. Dev., Strat. & IR	DDisposition to Issuer	−664 sh	—	—	0
2021-12-13	Hill-Rom Holdings, Inc.Restricted Stock Units (11/11/2020)D Disposition to Issuer	SVP, Corp. Dev., Strat. & IR	DDisposition to Issuer	−1,363 sh	—	—	0
2021-12-13	Hill-Rom Holdings, Inc.Restricted Stock Units (11/10/2021)D Disposition to Issuer	SVP, Corp. Dev., Strat. & IR	DDisposition to Issuer	−6,708 sh	—	—	0
2021-11-12	Hill-Rom Holdings, Inc.M Exercise/Conversion	SVP, Corp. Dev., Strat. & IR	MExercise/Conversion	+700 sh	—	—	2,537
2021-11-12	Hill-Rom Holdings, Inc.F Tax Payment	SVP, Corp. Dev., Strat. & IR	FTax Payment	−253 sh	$155.11	−$39.2K	2,284
2021-11-12	Hill-Rom Holdings, Inc.Restricted Stock Units (11/11/2020)M Exercise/Conversion	SVP, Corp. Dev., Strat. & IR	MExercise/Conversion	−700 sh	—	—	1,346
2021-11-11	Hill-Rom Holdings, Inc.M Exercise/Conversion	SVP, Corp. Dev., Strat. & IR	MExercise/Conversion	+2,018 sh	$94.14	+$190K	3,855
2021-11-11	Hill-Rom Holdings, Inc.S Sale	SVP, Corp. Dev., Strat. & IR	SSale	−2,018 sh	$155.14	−$313K	1,837
2021-11-11	Hill-Rom Holdings, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	SVP, Corp. Dev., Strat. & IR	MExercise/Conversion	−2,018 sh	—	—	6,054
2021-11-10	Hill-Rom Holdings, Inc.Restricted Stock Units (11/10/2021)A Award	SVP, Corp. Dev., Strat. & IR	AAward	+6,708 sh	—	—	6,708

Recent filings

Accepted (ET)
Sep 104
Ladone Mary Kay0001193125-26-388297
SEC(opens sec.gov)
Jun 94
Ladone Mary Kay0001760737-26-000005
SEC(opens sec.gov)
Jun 44
Ladone Mary Kay0001760737-26-000004
SEC(opens sec.gov)
Jan 64
Ladone Mary Kay0001076930-26-000011
SEC(opens sec.gov)
Sep 84
Ladone Mary Kay0000950170-25-113637
SEC(opens sec.gov)
Jul 144
Ladone Mary Kay0001127602-25-019140
SEC(opens sec.gov)
Jun 44
Ladone Mary Kay0001578563-25-000305
SEC(opens sec.gov)
May 164
Ladone Mary Kay0000950170-25-073842
SEC(opens sec.gov)
Jan 64
Ladone Mary Kay0001127602-25-000800
SEC(opens sec.gov)
Jul 154
Ladone Mary Kay0001127602-24-020378
SEC(opens sec.gov)
Jun 184
Ladone Mary Kay0001578563-24-000305
SEC(opens sec.gov)

Companies

Address

C/O KESTRA MEDICAL TECHNOLOGIES, LTD. 3933 LAKE WASHINGTON BLVD NE, SUITE 200

KIRKLAND, WA, 98033